Amneal Pharmaceuticals (AMRX) Goodwill & Intangibles (2017 - 2026)

Amneal Pharmaceuticals' Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 12.28% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (down 12.28% YoY), while the FY2025 annual figure was $1.2 billion, down 12.85% from the prior year.
• Goodwill & Intangibles was $1.1 billion for Q1 2026 at Amneal Pharmaceuticals, down from $1.2 billion in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $1.8 billion in Q1 2022 to a low of $1.1 billion in Q1 2026.
• Historically, Goodwill & Intangibles has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2024.
• The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles advanced 1.51% in 2022, then slipped 14.12% in 2025.
• A 5-year view of Goodwill & Intangibles shows it stood at $1.7 billion in 2022, then decreased by 12.15% to $1.5 billion in 2023, then dropped by 10.69% to $1.3 billion in 2024, then retreated by 12.85% to $1.2 billion in 2025, then retreated by 2.61% to $1.1 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.